These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 25585954)

  • 21. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage?
    Hesse S; Adhya S
    Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The next generation of bacteriophage therapy.
    Lu TK; Koeris MS
    Curr Opin Microbiol; 2011 Oct; 14(5):524-31. PubMed ID: 21868281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hurdles in bacteriophage therapy: deconstructing the parameters.
    Tsonos J; Vandenheuvel D; Briers Y; De Greve H; Hernalsteens JP; Lavigne R
    Vet Microbiol; 2014 Jul; 171(3-4):460-9. PubMed ID: 24315040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens.
    Burrowes B; Harper DR; Anderson J; McConville M; Enright MC
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):775-85. PubMed ID: 21905786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
    Kamal F; Dennis JJ
    Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage Production in Compliance with Regulatory Requirements.
    Pirnay JP; Merabishvili M; Van Raemdonck H; De Vos D; Verbeken G
    Methods Mol Biol; 2018; 1693():233-252. PubMed ID: 29119444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacteriophages and Their Immunological Applications against Infectious Threats.
    Criscuolo E; Spadini S; Lamanna J; Ferro M; Burioni R
    J Immunol Res; 2017; 2017():3780697. PubMed ID: 28484722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteriophages: potential treatment for bacterial infections.
    Duckworth DH; Gulig PA
    BioDrugs; 2002; 16(1):57-62. PubMed ID: 11909002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phage therapy pharmacology.
    Abedon ST; Thomas-Abedon C
    Curr Pharm Biotechnol; 2010 Jan; 11(1):28-47. PubMed ID: 20214606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.
    Colavecchio A; Goodridge LD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage approved in food, why not as a therapeutic?
    Sarhan WA; Azzazy HM
    Expert Rev Anti Infect Ther; 2015 Jan; 13(1):91-101. PubMed ID: 25488141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteriophages as potential treatment option for antibiotic resistant bacteria.
    Bragg R; van der Westhuizen W; Lee JY; Coetsee E; Boucher C
    Adv Exp Med Biol; 2014; 807():97-110. PubMed ID: 24619620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteriophage therapy: exploiting smaller fleas.
    Deresinski S
    Clin Infect Dis; 2009 Apr; 48(8):1096-101. PubMed ID: 19275495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Call for a dedicated European legal framework for bacteriophage therapy.
    Verbeken G; Pirnay JP; Lavigne R; Jennes S; De Vos D; Casteels M; Huys I
    Arch Immunol Ther Exp (Warsz); 2014 Apr; 62(2):117-29. PubMed ID: 24500660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phage therapy for respiratory infections].
    Mitropoulou G; Gijs PJ; Koutsokera A; Sauty A; Blanchon S; Csajka C; Brunet JF; Resch G; Guery B; Von Garnier C
    Rev Med Suisse; 2022 Nov; 18(804):2150-2156. PubMed ID: 36382975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phage therapy gets revitalized.
    Reardon S
    Nature; 2014 Jun; 510(7503):15-6. PubMed ID: 24899282
    [No Abstract]   [Full Text] [Related]  

  • 39. Phage therapy efficacy: a review of the last 10 years of preclinical studies.
    Melo LDR; Oliveira H; Pires DP; Dabrowska K; Azeredo J
    Crit Rev Microbiol; 2020 Feb; 46(1):78-99. PubMed ID: 32091280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European regulatory conundrum of phage therapy.
    Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP
    Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.